1 / 5

Beximco Pharmaceuticals Ltd Plans to Further Expand in Global Markets

This division of the Bangladeshi conglomerate, BEXIMCO Group, has initiated the start of the same. Its facilities and sources will enable it to succeed in expanding to new global markets. Moreover, new products and enhancements to the existing ones will benefit consumers.

BeximcoGroup
Download Presentation

Beximco Pharmaceuticals Ltd Plans to Further Expand in Global Markets

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. BEXIMCO PHARMACEUTICALS LTD PLANS TO FURTHER EXPAND IN GLOBAL MARKETS

  2. Committed to being a leading manufacturer of medicine or drugs, Beximco Pharmaceuticals Ltd. aims to broaden its operations. Globally, it has been accredited by various regulatory bodies based in Canada, the European Union (EU), the United States, Brazil, and Canada. The leader in the private sector in Bangladesh is well-regarded in these international markets. Further, it plans to expand its functioning in the Middle East.This division of the Bangladeshi conglomerate, BEXIMCO Group, has initiated the start of the same. Its facilities and sources will enable it to succeed in expanding to new global markets.

  3. Expansion in Saudi Arabia • Many industry experts and business consultants consider BEXIMCO Group as the leader in the private sector of Bangladesh. Beximco Pharmaceuticals Ltd. is the leading company in Bangladesh for the manufacture of generic drugs. To retain its strong position, it expanded not only within but beyond the country as well. In Saudi Arabia, in particular, it has set up a factory for further operations.

  4. Drug Exports in 60+ Destinations • In Bangladesh, Beximco Pharmaceuticals Ltd. is a major exporter and the leader in the private sector. It exports drugs to as many as 68 locations. They comprise important European and US-based markets. Its operations form around 20.3% of the overall exports of pharma products from the financial years 2018 to 2019 and 2022 to 2023.

  5. Producer of Active Pharmaceutical Ingredients • Presently, the pharmaceutical division of the Bangladeshi conglomerate produces APIs for some anti-bacterial and anti-inflammatory drugs. In addition, these are produced for certain anti-coagulants, anti-anginal medicine, and dipeptidyl peptidase-4 inhibitors. For the necessary imports, it counts on India and China. These are used for the production of other drugs.

More Related